Helen H. Liang

Solo GP · Menlo Park, CA

Helen H. Liang is a solo GP based in Menlo Park, CA focused on Healthcare, Biotech & Pharma, investing at pre-seed to growth stage. Helen H. Liang's most recent fund with a disclosed size, FoundersX Growth D, L.P., filed a $50M offering with the SEC in Apr 2024. Estimated typical check: $500K–$1.5M. Helen H. Liang's latest dated investing activity was in Apr 2025.

Why Helen H. Liang is listed

Named as the only individual (Managing Director of the General Partner of the Issuer) on the Form D for FoundersX Growth D, L.P., a $50M venture fund (Apr 2024). Also a non-executive director at 3 startups that filed Form D.

Source: SEC Form D: FoundersX Growth D, L.P. (Apr 23, 2024) · 3 more sources

Is this you? Remove or correct this profile.

Stages: Pre-seed to Growth
Typical check (est.): $500K–$1.5M
Latest fund: $50M · Apr 2024
Latest dated activity: Apr 2025

Is Helen H. Liang a fit for you?

See your fit score and the reason, contact details, and any warm path from your network.

Start 3-day trial to see contacts

What does Helen H. Liang invest in?

HealthcareBiotech & Pharma

What has Helen H. Liang invested in recently?

Cognito Therapeutics Group
Board seat on the company's SEC filing (not by itself proof of an investment) · MA
Apr 2025
FS2 Business
Board seat on the company's SEC filing (not by itself proof of an investment) · MO
Jan 2025
Markable
Board seat on the company's SEC filing (not by itself proof of an investment) · WA
Jun 2024
FoundersX Growth D, L.P.
Invested through a fund
Apr 2024

Funds and deal vehicles Helen H. Liang filed with the SEC

FoundersX Growth D, L.P.
Fund · $50M offering
Apr 2024

Sources

SEC Form D: FoundersX Growth D, L.P.Apr 23, 2024
SEC Form D (board seat): MarkableJun 6, 2024
SEC Form D (board seat): FS2 BusinessJan 22, 2025
SEC Form D (board seat): Cognito Therapeutics GroupApr 1, 2025

Data refreshed from public sources Oct 15, 2026. Is this you? Remove or correct this profile.